therapeut
strategi
base
mirna
technolog
treatment
viral
diseas
progress
rapidli
although
new
gener
molecular
therapi
promis
still
sever
challeng
face
target
deliveri
specif
tissu
avoid
offtarget
effect
mirna
reduc
toxic
drug
overcom
mutat
drug
resist
articl
review
current
knowledg
role
therapeut
potenti
mirna
viral
diseas
discuss
limit
therapi
well
strategi
overcom
provid
safe
effect
clinic
applic
new
therapeut
rna
interfer
rnai
system
live
cell
regul
activ
silenc
gene
express
rnai
govern
regul
host
cell
gene
mainli
two
type
rna
molecul
small
interf
rna
sirna
microrna
mirna
sirna
class
doublestrand
rna
molecul
nucleotid
length
play
differ
role
cellular
biolog
experiment
applic
target
sirna
variou
cell
type
anim
model
shown
promis
potenti
treatment
diseas
induc
virus
hepat
c
influenza
hiv
suppress
viral
gene
express
sirna
make
attract
antivir
therapi
sirna
alreadi
use
clinic
trial
howev
sirna
still
long
way
go
brought
market
potenti
side
effect
one
major
concern
use
sirna
molecular
therapeut
induct
strong
immun
respons
mirna
discov
group
noncod
singlestrand
rna
molecul
rang
size
nucleotid
believ
mirna
compos
one
percent
total
human
genom
mirna
wide
express
variou
speci
includ
virus
first
viral
encod
mirna
discov
epstein
barr
viru
ebv
genom
identifi
mirna
encod
virus
expect
identifi
near
futur
result
improv
onlin
predict
valid
tool
cellular
mirna
anim
seem
conserv
viral
encod
mirna
highli
variabl
even
within
group
virus
may
due
high
frequenc
viral
mutat
rel
eukaryot
mirna
play
import
role
regul
almost
onethird
known
human
mrna
mirna
specif
tissu
express
profil
uniqu
express
pattern
may
explain
role
differ
biolog
activ
cellular
differenti
environ
adapt
oncogenesi
hostpathogen
interact
therapeut
potenti
mirna
first
realiz
discoveri
downregul
associ
develop
bcell
leukemia
shortli
potenti
treatment
sever
cancer
realiz
scientist
aim
control
express
level
key
gene
via
manipul
cellular
viral
mirna
treat
diseas
approach
includ
antimirna
oligonucleotid
amo
peptid
nucleic
acid
mirna
spong
initi
experi
obtain
promis
result
control
variou
viral
infect
addit
found
restor
overexpress
certain
mirna
may
also
benefici
revers
patholog
condit
especi
cancer
treatment
goal
articl
review
recent
progress
understand
role
mirna
viral
diseas
discuss
potenti
molecul
serv
therapeut
target
use
therapeut
tool
also
specif
highlight
major
obstacl
face
mirna
technolog
therapeut
vaccin
strategi
virus
oblig
intracellular
parasit
lack
essenti
machineri
requir
replic
thu
virus
adopt
sever
clever
strategi
ensur
success
replic
suitabl
host
one
manipul
host
mirna
modifi
cellular
environ
benefit
dna
virus
capabl
encod
mirna
modul
viral
cellular
protein
express
order
provid
favor
environ
viral
replic
answer
back
certain
host
mirna
alter
cell
gene
express
defend
cell
viral
infect
interf
viral
protein
cellular
factor
type
immun
respons
particular
virus
therefor
relationship
virus
mirna
complic
say
least
sinc
mirna
play
essenti
role
viral
infect
consid
promis
therapeut
target
infecti
diseas
endogen
natur
small
size
flexibl
function
make
mirna
good
candid
may
trigger
lower
immunogen
respons
fewer
side
effect
sirna
view
current
data
regard
role
differ
viral
cellular
mirna
variou
viral
replic
cycl
believ
manipul
mirna
promis
therapeut
role
infecti
diseas
current
mirna
encod
human
genom
alon
discuss
role
therapeut
potenti
cellular
well
viral
mirna
pathogenesi
treatment
differ
viral
diseas
human
polyomavirus
hpyv
group
oncogen
circular
nonenvelop
doublestrand
dna
dsdna
virus
five
polyomavirus
found
infect
human
particular
interest
two
strain
virus
name
accord
initi
first
affect
patient
bk
viru
bkv
jame
canyon
viru
jcv
reservoir
speci
human
infect
rhesu
macaqu
human
also
acquir
simian
viru
infect
contamin
polioviru
vaccin
recent
studi
report
horizont
transmiss
peopl
hpyv
induc
wide
rang
tumor
affect
almost
bodi
organ
includ
brain
bone
colon
pancrea
stomach
urogenit
tract
well
lymphoma
leukemia
viral
genom
encod
five
protein
two
larg
antigen
lt
one
small
antigen
stag
three
encod
capsid
protein
hpyv
abl
encod
viral
mirna
benefit
bkv
jcv
encod
mirna
name
upregul
brain
progress
multifoc
leukoencephalopathi
syndrom
suggest
major
role
particular
diseas
encod
mirna
call
vmirna
late
stage
infect
complementari
viral
mrna
produc
earli
stage
viral
infect
vmirna
slow
express
viral
tantigen
gene
lower
level
interferon
ifn
g
produc
cytotox
lymphocyt
thu
reduc
influx
inflammatori
cell
facilit
evas
immun
respons
human
papillomavirus
hpv
also
oncogen
virus
usual
associ
differ
form
benign
malign
tumor
especi
affect
skin
genit
tract
virus
usual
classifi
basi
virul
either
lowor
highpathogen
variant
hpv
strain
produc
mirna
replic
exampl
encod
viral
mirna
earli
stage
infect
mirna
usual
degrad
latent
infect
take
place
anoth
independ
studi
found
encod
viral
mirna
involv
cell
transform
cancer
develop
well
known
host
involv
inhibit
abnorm
cell
growth
tumor
inhibit
cell
cycl
progress
phase
subsequ
induc
apoptosi
studi
report
success
use
tumor
suppressor
complex
mrnacellular
target
downstream
gene
tumor
protein
usual
downregul
hpv
infect
primari
keratinocyt
thu
restor
normal
express
level
mirna
potenti
strategi
therapeut
intervent
adenovirus
group
nonenvelop
dsdna
virus
serotyp
identifi
differ
clinic
diseas
respiratori
gastrointestin
urogenit
eye
diseas
adenoviru
usual
encod
sever
small
noncod
rna
molecul
call
virusassoci
rna
facilit
immun
evas
inhibit
dsrnainduc
protein
kinas
r
pkr
block
ifna
activ
one
studi
report
adenoviru
interfer
biogenesi
host
mirna
function
sirna
shrna
short
hairpin
rna
inhibit
nuclear
transport
premirna
shrna
direct
inhibitori
action
dicer
usual
small
part
rna
subject
process
dicer
result
gener
mirna
use
antimirna
antisens
inhibitor
omethyl
amo
downregul
mirna
result
inhibit
viru
product
herpesvirus
group
envelop
dsdna
virus
classifi
three
subfamili
b
g
character
induct
latent
infect
target
host
virusencod
mirna
play
import
role
establish
latent
infect
well
pathogenesi
viral
induc
diseas
accord
recent
studi
herpesvirus
util
encod
mirna
wide
rang
biolog
function
inhibit
apoptosi
immun
evas
control
cellular
prolifer
regul
viral
replic
follow
section
discuss
herpesvirusencod
mirna
one
import
gene
encod
herp
simplex
viru
hsv
call
latencyassoci
transcript
lat
gene
encod
protein
may
involv
product
mirna
cell
surviv
viral
infect
debat
around
origin
mirlat
whether
virusencod
cellencod
mirna
mirna
believ
act
downregul
transform
growth
factor
tgf
b
tgfb
play
import
role
cell
prolifer
induct
apoptosi
signal
pathway
mediat
trigger
action
tgfb
recent
discov
infect
accord
bioinformat
analysi
genom
encod
mirna
eight
found
conserv
thu
believ
function
six
mirna
upregul
trigemin
ganglia
mice
infect
mirna
encod
lat
tabl
addit
quantit
revers
transcript
pcr
show
highli
express
vero
cell
infect
high
copi
respect
wherea
four
mirna
show
downregul
copi
per
infect
cell
mirna
express
profil
infect
reveal
sever
mirna
among
eight
candid
mention
earlier
upregul
mirna
believ
play
major
role
induct
latent
phase
viral
infect
assumpt
base
comparison
mirna
express
profil
latent
activ
infect
exampl
found
upregul
latent
infect
level
copi
cell
compar
less
copi
cell
activ
infect
furthermor
inhibit
product
infect
cell
polypeptid
icp
protein
respons
trigger
activ
phase
hsv
infect
anoth
upregul
mirna
respons
downregul
respons
increas
express
level
mani
hsv
gene
activ
phase
infect
human
cytomegaloviru
hcmv
herpesvirus
affect
human
result
acut
latent
infect
form
infect
larg
depend
immun
statu
affect
host
fatal
immunecompromis
patient
aid
recent
organ
transplant
may
also
respons
birth
defect
congenit
abnorm
pregnant
women
herpesvirus
evid
support
presenc
mirna
modul
viral
pathogenesi
differ
tissu
specif
hcmv
recent
report
encod
mirna
commonli
express
three
mirna
activ
phase
hcmv
infect
target
differ
cellular
protein
transcript
factor
receptor
receptor
protein
involv
signal
transduct
pathway
hcmv
abl
induc
latent
phase
infect
cun
immuneevas
strategi
action
target
sever
cellular
protein
major
histocompat
complex
mhc
class
associ
protein
especi
mhc
class
irel
chain
b
micb
also
regul
earli
viral
protein
express
immedi
earli
protein
ie
key
mediat
shift
latent
activ
phase
viral
infect
suppress
thu
hcmv
infect
synchron
overexpress
protein
express
level
greatli
reduc
mediat
latent
phase
infect
also
thought
target
anoth
viral
protein
call
downregul
protein
use
result
inhibit
viral
dna
replic
subsequ
trigger
latent
phase
infect
make
viru
abl
evad
host
immun
system
exploit
mechan
consid
potenti
therapeut
strategi
ebv
anoth
oncogen
viru
affect
human
usual
associ
induct
latent
infect
affect
patient
case
benign
tumor
develop
case
howev
malign
tumor
may
also
develop
hodgkin
lymphoma
tcell
lymphoma
nasopharyng
carcinoma
gastric
tumor
activ
phase
ebv
infect
gene
usual
express
wherea
express
latent
infect
recent
report
ebv
encod
mirna
mirna
divid
two
group
one
group
encod
intron
region
gene
call
bart
express
high
level
epitheli
cell
lower
level
b
cell
latent
phase
infect
group
encod
untransl
region
gene
call
viral
homolog
prevent
apoptosi
although
function
ebvencod
mirna
complet
identifi
found
target
mrna
viral
dna
polymeras
induc
cleavag
untransl
region
utr
result
inhibit
lytic
viral
infect
figur
tabl
accord
bioinformat
predict
data
ebv
believ
target
puma
modul
apoptosi
protein
group
regul
case
puma
also
induc
apoptosi
pathway
therefor
target
puma
ebv
result
suppress
action
apoptosi
ebvencod
mirna
target
ifnginduc
chemokin
without
ebv
abl
evad
host
immun
respons
subsequ
enhanc
ebv
replic
group
perform
bioinformat
analysi
show
contain
target
sequenc
utr
sequenc
target
use
viral
encod
mirna
immunomodulatori
effect
viralinduc
tumor
therefor
believ
target
could
good
therapeut
approach
viral
ebvinduc
tumor
kshv
one
gammaherp
virus
group
usual
associ
kaposi
sarcoma
infect
acquir
name
like
herpesvirus
kshv
usual
induc
latent
infect
kshv
encod
sever
mirna
candid
genom
region
span
kilobas
kshvencod
mirna
target
import
gene
involv
cell
prolifer
modul
host
immun
system
apoptosi
angiogenesi
exampl
target
mrna
prosurviv
gene
interact
protein
call
lead
reactiv
kshv
lytic
infect
thu
kshvencod
mirna
play
import
role
viru
host
interact
silenc
mirna
use
differ
approach
particularli
amo
therefor
promis
therapeut
strategi
viru
infect
figur
marek
diseas
viru
mdv
one
alpha
herpesvirus
character
rapid
product
tcell
lymphoma
chicken
viral
genom
encod
sever
mirna
mainli
encod
oncogen
especi
meq
lat
mirna
viru
highli
express
mdvtransform
cell
suggest
essenti
role
mdv
oncogenesi
howev
target
gene
well
identifi
known
sever
host
cell
mirnassuch
involv
cancer
develop
induc
mdv
chicken
often
upregul
mdvtransform
tcell
line
deriv
spleen
lymphoma
induc
strain
librari
mdv
infect
make
ideal
model
studi
mirna
compar
analysi
mirna
express
profil
mdv
infect
use
microarray
analysi
may
enabl
identif
specif
mirna
involv
neoplast
transform
compar
noninfect
cell
may
becom
use
diagnost
approach
examin
mirna
signatur
profil
support
recent
report
show
associ
downregul
host
cellular
express
upregul
mdvencod
mirna
potenti
marker
mdvinduc
tumor
format
subsequ
identif
put
target
mirna
lead
better
understand
molecular
mechan
mdvinduc
tumorigenes
human
immunodefici
viru
hiv
genom
encod
sever
import
gene
nef
vef
tat
vpu
bioinformat
analysi
suggest
hiv
genom
encod
five
premirna
process
ten
matur
mirna
definit
function
still
well
identifi
hiv
nef
gene
locat
end
hiv
genom
highli
express
earli
viral
infect
shown
downregul
express
level
mhc
class
molecul
hiv
nef
encod
uniqu
function
transcript
translat
level
rather
posttranscript
level
mechan
action
believ
suppress
hiv
promot
activ
howev
studi
requir
explain
exact
mechan
action
sever
studi
report
downregul
nef
gene
result
inhibit
hiv
replic
may
lead
product
lowpathogen
strain
hiv
may
favor
latent
hiv
infect
target
viral
mirna
use
differ
approach
especi
amo
treatment
could
potenti
therapeut
effect
hiv
hybrid
correspond
target
host
gene
blue
sequenc
viral
mirna
sequenc
untransl
region
utr
sequenc
target
host
viral
gene
obtain
referenc
articl
nation
center
biotechnolog
inform
ncbi
websit
submit
rnahybrid
softwar
program
http
bibiservtechfak
unibielefelddernahybrid
predict
secondari
structur
hybrid
viral
mirna
target
gener
rnahybrid
program
encod
kaposi
sarcomaassoci
herpesviru
kshv
target
host
gene
transcript
factor
b
encod
ebv
target
viral
dna
polymeras
gene
c
encod
herpesvirus
target
host
gene
micb
mhc
class
irel
chain
b
mfe
minimum
free
energi
current
million
peopl
affect
hepat
c
viru
hcv
infect
worldwid
drug
resist
one
major
hindranc
treat
viral
infect
hcv
induc
differ
form
tumor
human
one
major
caus
liver
diseas
world
result
hepatocellular
carcinoma
final
complet
liver
failur
recent
report
host
cellular
two
recognit
site
utr
hcv
genom
result
upregul
hcv
infect
investig
show
interact
viral
genom
caus
accumul
viral
rna
liver
tissu
tabl
furthermor
level
viral
rna
liver
tissu
usual
control
bind
site
interestingli
hcv
infect
also
modul
cellular
mirna
express
profil
follow
hcv
infect
three
mirna
upregul
two
mirna
downregul
ura
et
al
found
cyclin
act
put
target
use
primat
model
target
specif
antagonist
result
reduct
level
hcv
replic
affect
liver
demonstr
promis
strategi
addit
recent
studi
demonstr
therapeut
potenti
silenc
chronic
hcv
viral
infect
primat
model
wherebi
chimpanze
posit
hcv
infect
treat
specif
lnamodifi
oligonucleotid
lnaoligom
target
complement
sequenc
result
decreas
durat
viremia
follow
acut
hcv
infect
report
side
effect
viral
resist
observ
treatment
approach
provid
longlast
effect
hcvinfect
anim
well
great
improv
liver
patholog
clinic
trial
need
confirm
promis
result
new
molecular
therapeut
approach
hepat
b
viru
hbv
belong
genu
orthohepadnaviru
famili
hepadnavirida
hbv
infect
progress
cirrhosi
hepatocellular
carcinoma
case
believ
hbv
encod
mirna
regul
gene
express
accord
bioinformat
predict
hbv
encod
one
mirna
howev
sever
studi
fail
identifi
cellular
gene
regul
virusencod
mirna
impli
altern
gene
express
mechan
accord
mirna
express
profil
sever
patient
suffer
cirrhosi
due
hbv
infect
host
usual
upregul
recent
clinic
studi
ura
et
al
studi
role
differ
mirna
pathogenesi
hbv
hcv
context
develop
hepatocellular
carcinoma
infect
liver
tissu
studi
differenti
express
level
mirna
hbv
hcv
patient
test
use
qrtpcr
accord
studi
mirna
candid
highli
express
hbv
hcv
infect
mirna
serv
marker
sever
liver
damag
known
hbv
infect
trigger
pathway
associ
dna
damag
recombin
signal
transduct
pathway
wherea
hcv
infect
usual
trigger
immun
respons
antigen
present
cell
cycl
progress
proteosom
activ
lipid
metabol
therefor
overal
conclus
certain
mirna
may
act
import
mediat
pathogenesi
hbv
hcv
infect
studi
pave
way
new
era
molecular
antivir
therapi
modul
express
level
key
mirna
new
antivir
therapi
control
hbv
infect
use
artifici
mirna
approach
reveal
dramat
reduct
hbv
protein
express
level
remark
reduct
viral
dna
replic
vitro
sever
acut
respiratori
syndrom
coronaviru
sarscov
singlestrand
rna
viru
belong
famili
coronavirida
although
sever
trial
perform
treat
pathogen
use
convent
drug
ribavirin
antibiot
antiinflammatori
steroid
differ
kind
immun
stimul
approach
still
lack
viral
specif
sarscov
infect
bronchioalveolar
stem
cell
basc
prime
exampl
mirna
modul
virushost
interact
sarscov
unabl
replic
well
differenti
cell
control
basc
cellular
differenti
order
establish
success
viral
infect
viru
usual
hijack
cellular
mirna
benefit
replic
immun
evas
nucleocapsid
spike
glycoprotein
downregul
express
level
respect
action
enabl
viru
hinder
basc
cellular
differenti
product
inflammatori
chemokin
creat
environ
optim
viru
replic
restor
level
pose
potenti
novel
approach
treat
sarscov
infect
influenza
outbreak
provid
warn
urgent
need
new
altern
molecular
therapeut
approach
treatment
prophylaxi
viral
infect
molecular
therapi
use
mirna
technolog
may
offer
new
therapeut
approach
cope
continu
chang
viru
strain
everi
year
recent
bioinformat
tool
pave
way
discoveri
new
mirna
target
sequenc
design
nucleic
acidbas
therapeut
exampl
two
humanencod
mirna
potenti
bind
site
within
viral
polymeras
hemagglutinin
ha
gene
respect
tabl
target
sequenc
two
mirna
highli
conserv
among
differ
influenza
viru
strain
ha
protein
involv
attach
viru
receptor
protein
essenti
compon
ribonucleoprotein
complex
need
rna
transcript
replic
presenc
human
mirna
target
conserv
region
influenza
rna
suggest
human
genom
evolv
use
defens
mechan
infect
support
argument
target
viral
gene
mirna
may
effect
strategi
may
also
suggest
futil
attempt
sinc
mirna
yet
still
succumb
influenza
infect
recent
studi
conduct
determin
mirna
express
profil
avian
influenza
viru
aiv
infect
chicken
studi
show
chang
cellular
mirna
profil
respons
aiv
infect
suggest
mirna
play
role
hostpathogen
interact
aiv
infect
specif
alter
mirna
profil
previous
report
play
role
immunerel
signal
pathway
mammal
one
recent
studi
util
mirna
technolog
develop
influenza
viru
vaccin
wherebi
new
influenza
viru
vaccin
develop
use
mirnabas
gene
silenc
method
involv
introduc
mirna
sequenc
nonavian
origin
known
mirnarespons
element
mre
viral
nucleoprotein
gene
result
construct
new
reassort
virus
strategi
degre
viral
attenu
control
express
level
target
introduc
mre
sequenc
novel
strategi
offer
good
vaccin
speci
specif
offer
high
level
protect
nascent
virus
attenu
mice
still
propag
well
embryon
chicken
egg
abl
gener
high
level
neutral
antibodi
anim
novel
approach
influenza
vaccin
develop
may
use
combin
current
avail
vaccin
order
increas
safeti
efficaci
influenza
viru
vaccin
near
futur
coxsackieviru
especi
coxsackieviru
common
pathogen
human
myocard
drug
develop
recent
focus
nucleic
acidbas
strategi
laboratori
first
report
success
inhibit
replic
hela
cell
transfect
sirna
target
viral
proteas
rna
also
found
antivir
effect
disrupt
mutat
central
strand
region
mismatch
toler
near
end
near
end
sirna
furthermor
sirna
effect
mediat
antisens
strand
viral
genom
rather
sens
strand
complimentari
viral
negativestrand
replic
intermedi
find
conform
anoth
report
appli
system
mice
sirna
target
signific
protect
effect
appli
hour
infect
includ
reduc
viral
replic
tissu
injuri
well
increas
surviv
rate
recent
test
packag
rna
prna
vector
compon
bacteri
phage
nanomotor
target
deliveri
sirna
conjug
folat
ligand
prna
vector
specif
deliv
sirna
target
hela
cell
cardiomyocyt
express
folat
receptor
addit
transfect
matur
sirna
overexpress
shrna
also
effect
rna
polymeras
structur
protein
cell
mice
viral
pancreat
significantli
reduc
schubert
et
al
use
sidex
doubl
express
vector
simultan
transfect
two
sirna
sequenc
target
rna
polymeras
sequenc
green
fluoresc
protein
gfp
report
construct
doubl
express
sirna
success
suppress
report
express
despit
intent
introduct
artifici
point
mutat
simul
escap
mutat
mirna
target
caus
mismatch
one
two
sirna
discuss
promis
result
support
develop
mirna
treatment
sever
viral
infect
mirnabas
drug
reach
clinic
trial
stage
despit
great
progress
clinic
applic
still
hamper
sever
challeng
follow
section
briefli
discuss
current
obstacl
limit
face
mirnasbas
antivir
therapi
one
major
limit
use
mirnabas
antivir
therapi
product
transgenespecif
immun
deliveri
mirna
use
viral
vector
usual
result
develop
immun
respons
viral
vector
basic
deliveri
vector
stimul
innat
immun
respons
form
cytotox
tlymphocyt
humor
neutral
antibodi
viral
capsid
protein
cytokinemedi
inflammatori
respons
vivo
direct
correl
immun
respons
adenoviru
capsid
protein
concentr
viral
vector
report
interact
usual
associ
undesir
side
effect
host
especi
construct
move
target
tissu
blood
circul
target
deliveri
sirna
mirna
nucleic
acidbas
therapi
anoth
major
concern
use
molecular
therapeut
approach
contrast
great
progress
local
administr
sirnaand
mirnabas
therapi
eye
lung
vagina
system
deliveri
target
organ
liver
heart
intestin
still
undergo
optim
interest
note
studi
shown
success
administ
sirna
via
intracerebr
rout
howev
risk
foreign
nucleic
acid
may
deliv
central
nervou
system
sever
laboratori
techniqu
realtim
pcr
microarray
analysi
luminex
bead
array
northern
blot
situ
hybrid
formalin
fixat
paraffin
embed
current
use
mirna
detect
quantif
howev
techniqu
still
requir
optim
optim
clear
choic
sensit
specif
emerg
approach
allow
earli
sensit
detect
mirna
express
differ
diseas
syndrom
great
impact
earli
track
seriou
viral
diseas
offtarget
effect
sirna
one
major
concern
earlier
studi
use
sirna
shrna
technolog
gene
therapi
new
gener
molecular
gene
therapi
mirna
would
expect
high
degre
specif
target
howev
sinc
mirna
action
base
imperfect
base
pair
target
sequenc
circumst
specif
lower
sirna
predict
confirm
recent
clinic
trial
follow
microarray
analysi
reveal
possibl
offtarget
effect
mirna
anoth
followup
studi
birmingham
et
al
use
combin
bioinformat
microarray
analysi
found
use
either
sirna
mirna
could
result
offtarget
silenc
addit
vivo
studi
reveal
one
mirna
may
target
sever
gene
time
target
clearli
identifi
suggest
divers
mode
action
given
singl
mirna
hand
one
gene
may
regul
sever
mirna
indic
mode
action
complic
expect
sinc
drug
therapi
must
precis
target
viru
question
noth
els
larg
undertak
need
gather
possibl
inform
regard
target
mirna
consid
drug
develop
although
current
use
viral
vector
mirna
deliveri
nonpathogen
alway
possibl
mutat
within
viral
vector
mutat
may
result
abnorm
gene
express
viral
mirna
construct
may
also
caus
possibl
insert
vector
human
genom
increas
risk
cancer
moreov
target
virus
especi
rna
virus
prone
mutat
may
drive
drug
resist
current
two
possibl
approach
conquer
issu
one
target
cellular
factor
essenti
viru
replic
use
one
mirna
target
gene
possibl
solut
target
sever
conserv
region
viral
genom
differ
sirna
mirna
virus
among
common
caus
human
diseas
uniqu
biolog
properti
virus
effect
specif
antivir
therapi
avail
far
sever
vaccin
antivir
drug
shown
limit
degre
efficaci
prophylaxi
treatment
viral
infect
howev
high
mutat
rate
enabl
viral
diseas
emerg
reemerg
frequent
thu
new
strategi
drug
vaccin
develop
must
devis
fight
threat
viral
diseas
human
health
recent
advanc
understand
mirna
structur
function
particularli
associ
molecular
pathogenesi
varieti
complex
diseas
serv
theoret
basi
drug
develop
one
hand
key
factor
viral
replic
latenc
mirna
ideal
target
inhibit
regard
construct
mrna
contain
multipl
tandem
bind
site
given
mirna
may
use
produc
decoy
mirna
spong
inhibit
function
specif
mirna
addit
chemic
synthes
antisens
rna
oligom
antagomir
target
mirna
interest
could
also
promis
approach
inhibit
mirna
activ
hand
mirna
express
vector
use
overexpress
specif
mirna
achiev
longterm
effect
revers
imbal
mirna
express
caus
infect
introduct
premirna
mimet
transient
replac
anoth
option
investig
summari
although
mani
limit
present
believ
rapid
progress
mirna
research
small
molecul
becom
invalu
target
use
tool
basic
research
drug
develop
expect
mirnabas
antivir
therapi
becom
avail
clinic
applic
near
futur
